About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
Publications
Disease Area
Hyperphosphatemia
IBS-C
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Filter
Tenapanor Treatment of Patients with Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
The American Journal of Gastroenterology
Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis
Journal of the American Society of Nephrology
Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice
Journal of Cardiovascular Pharmacology and Therapeutics
Palatability and Physical Properties of Potassium-Binding Resin Rdx7675: Comparison with Sodium Polystyrene Sulfonate
Drug Design, Development and Therapy
A Common NHE3 Single-Nucleotide Polymorphism has Normal Function and Sensitivity to Regulatory Ligands
American Journal of Physiology-Gastrointestinal and Liver Physiology
Pages:
1
2
3
4
5
6
7
8
Load More
Sorry, nothing found in this query